Cetera Investment Advisers

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Investment type: Debt / NOTE 1.250% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$9,579	10,000	0		95.79%	Q4 2025
30 Sep 2025	0%	0%	$9,480	10,000	0		94.8%	Q3 2025
30 Jun 2025	0%	0%	$9,413	10,000	0		94.13%	Q2 2025
31 Mar 2025	0%	-0%	$9,405	10,000	-158,000		94.05%	Q1 2025
31 Dec 2024	0%	-0%	$155,904	168,000	-30,000	-15%	92.8%	Q4 2024
30 Sep 2024	0%	+0%	$188,199	198,000	+2,000	+1%	95.05%	Q3 2024
30 Jun 2024	0%	+0%	$187,125	196,000	+79,000	+68%	95.47%	Q2 2024
31 Mar 2024	0%	+0%	$115,397	117,000	+117,000	NEW	98.63%	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.